GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vincerx Pharma VINC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.02

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Vincerx Pharma — daily VINC Delayed
Market value
$78,450
Last close × shares
Volume
177
Shares, 9 Nov 2026

About Vincerx Pharma

Its shares trade under the ticker VINC. It has been listed since 10 March 2020.

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. The company is headquartered in Palo Alto, California. The company went IPO on 2020-03-10. The Company’s pipeline consists of enitociclib, which is in Phase I, and a modular bioconjugation platform, which includes a small molecule drug-conjugate (SMDC), VIP236, in Phase I, and preclinical next-generation antibody drug-conjugates, VIP943 and VIP924. Enitociclib, is a highly selective cyclin-dependent kinase 9 (CDK9) inhibitor. The firm's antibody-drug conjugate (ADC) platform includes VIP943 and VIP924, which are ADC compounds addressing known and oncology targets. The bioconjugation program also includes VIP236, which is a small molecule drug conjugate (SMDC) for solid tumors. VIP236 is a SMDC with a focus on treating patients with cancers.

Figures and description from our data supplier, not checked against the company's own report.

More about Vincerx Pharma →

Latest on Vincerx Pharma

Our reporting

We have not reported on Vincerx Pharma yet.

Next results

10 Nov 2026

Due on 10 Nov 2026. Analysts expect earnings of -8.00 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Vincerx Pharma's ticker?

Vincerx Pharma trades as VINC on its US listing, under ISIN US92731L3042.

What was Vincerx Pharma's last closing price?

0.02 on 9 Nov 2026. The figure is in USD and is never converted.

When does Vincerx Pharma next report results?

Results are expected on 10 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.